HR1076-118 · 118th Congress
Signed
Signed Sep 13, 2024Preventing the Financing of Illegal Synthetic Drugs Act
Preventing the Financing of Illegal Synthetic Drugs Act This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
VOTE BREAKDOWN
Final passage · 360 politicians tracked
335
YEA
1
NAY
0
PRESENT
24
NOT VOTING
Dem YEA 161Ind YEA 1Rep NAY 1Rep YEA 173
BY PARTY · ✕ NAY ← | → YEA ✓
DEM
0
161
REP
1
173
IND
0
1
MONEY ON THIS BILL
Which donor industries fund each side of the vote — total contributions from that industry to those members, all cycles · plus lobbying activity in affected industries
⬆ YEA voters — top donor industries
- 1. Lawyers & Lobbyists$196.9M
- 2. Securities & Investment$136.7M
- 3. Health Services$131.1M
⬇ NAY voters — top donor industries
- 1. Technology$293K
- 2. Lawyers & Lobbyists$249K
- 3. Health Services$227K
◎ Lobbying activity by issue area
No bill-issue lobbying matches.
Dollar figures are each industry's total contributions to those members across all tracked cycles — not money given for this specific bill. Statistical patterns in public records; correlation, not causation.
LOBBYING ON THIS BILL
7 federal lobbying reports name this bill in their activity descriptions · LDA disclosures
NATIONAL ASSOCIATION OF MUTUAL INSURANCE COMPANIES5 reports
AFL-CIO2 reports
A report naming a bill means the organization disclosed lobbying activity on it — the disclosure does not state a position for or against.
INDIVIDUAL VOTES
Recorded positions for tracked politicians
SPONSORS
Monica De La Cruz
R-TX · Primary
7 COSPONSORS
BIPARTISAN● 3 D● 4 R
+1 more (see dot grid above)
SPONSOR FUNDING
Top industries funding Cruz
Party & Leadership24%
Party & Leadership 24% of classified donations
Single-Issue Advocacy17%
Single-Issue Advocacy 17% of classified donations
Securities & Investment16%
Securities & Investment 16% of classified donations
Real Estate14%
Real Estate 14% of classified donations
Agriculture6%
Agriculture 6% of classified donations
TRAIL AI
HR 1076, the Preventing the Financing of Illegal Synthetic Drugs Act, addresses measures to restrict funding streams for the production and distribution of illegal synthetic drugs. The bill passed the House with overwhelming bipartisan support, receiving 335 yes votes and 1 no vote, with Democrats voting 161-0 in favor and Republicans voting 173-1 in favor. The legislation has been signed into law.
Based on public voting records. Does not imply causation.
TIMELINE
INTRODUCEDFeb 17, 2023
PASSED SENATEJul 23, 2024
SIGNEDSep 13, 2024
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.